500
0
0
Skip to Content
Lung Cancer Europe | Advocacy and Access for Lung Cancer in Europe
🔍
Overview
Our Board
Brand hub
Contact
Policy and resources
11th Report
11th Report Press Release
10th Report
English
Lung Cancer Europe | Advocacy and Access for Lung Cancer in Europe
🔍
Overview
Our Board
Brand hub
Contact
Policy and resources
11th Report
11th Report Press Release
10th Report
English
🔍
Folder: Who We Are
Back
Overview
Our Board
Brand hub
Contact
Policy and resources
Folder: Annual Reports
Back
11th Report
11th Report Press Release
10th Report
English
Back
No results found
A new ROS1 lung cancer drug has reached patients in the US. What happens next in Europe?
Treatment, Access, News Web Team 25/07/2026 Treatment, Access, News Web Team 25/07/2026

A new ROS1 lung cancer drug has reached patients in the US. What happens next in Europe?

Read More
Lung Cancer Europe’s position on artificial intelligence in lung cancer care
News, Treatment, Advocacy, Research Web Team 25/07/2026 News, Treatment, Advocacy, Research Web Team 25/07/2026

Lung Cancer Europe’s position on artificial intelligence in lung cancer care

Read More
Why People with Lung Cancer Face a Higher Risk of Hospital Infections
Prevention & risk, Policy, Treatment, Advocacy, LuCE News, News Web Team 24/07/2026 Prevention & risk, Policy, Treatment, Advocacy, LuCE News, News Web Team 24/07/2026

Why People with Lung Cancer Face a Higher Risk of Hospital Infections

Read More
BMI, the Gut Microbiome and Immunotherapy: New Nature Study Explores the Obesity Paradox
News, Treatment, Research Web Team 19/07/2026 News, Treatment, Research Web Team 19/07/2026

BMI, the Gut Microbiome and Immunotherapy: New Nature Study Explores the Obesity Paradox

Read More
TROP2 and lung cancer: what we know so far
News, Treatment, Research Web Team 17/07/2026 News, Treatment, Research Web Team 17/07/2026

TROP2 and lung cancer: what we know so far

Read More
How Doctors Find and Remove Tiny Lung Nodules
Treatment, Diagnosis, News Web Team 14/07/2026 Treatment, Diagnosis, News Web Team 14/07/2026

How Doctors Find and Remove Tiny Lung Nodules

Read More
New Treatments for Small Cell Lung Cancer in Europe
Treatment, Research, Advocacy, News Web Team 10/07/2026 Treatment, Research, Advocacy, News Web Team 10/07/2026

New Treatments for Small Cell Lung Cancer in Europe

Read More
CAR T Cells and Lung Cancer: Could This Immunotherapy Become a Future Treatment?
Treatment, Research, News Web Team 07/07/2026 Treatment, Research, News Web Team 07/07/2026

CAR T Cells and Lung Cancer: Could This Immunotherapy Become a Future Treatment?

Read More
Patient-reported outcomes: asking people with lung cancer how they are
Advocacy, Treatment, News Web Team 05/07/2026 Advocacy, Treatment, News Web Team 05/07/2026

Patient-reported outcomes: asking people with lung cancer how they are

Read More
The Microbiome and Lung Cancer: How Gut Bacteria Could Change Treatment
News, Treatment, Research Web Team 04/07/2026 News, Treatment, Research Web Team 04/07/2026

The Microbiome and Lung Cancer: How Gut Bacteria Could Change Treatment

Read More
Access to Treatment Atlas: compare lung cancer treatment access across Europe
News, Advocacy, Treatment Web Team 01/07/2026 News, Advocacy, Treatment Web Team 01/07/2026

Access to Treatment Atlas: compare lung cancer treatment access across Europe

Read More
What the EU Critical Medicines Act means for lung cancer
News, Treatment, Advocacy Web Team 01/07/2026 News, Treatment, Advocacy Web Team 01/07/2026

What the EU Critical Medicines Act means for lung cancer

Read More
England catches up on cemiplimab for advanced lung cancer
News, Access, Treatment Web Team 01/07/2026 News, Access, Treatment Web Team 01/07/2026

England catches up on cemiplimab for advanced lung cancer

Read More
HARMONi-7: European sites now open for Phase 3 ivonescimab trial in high PD-L1 NSCLC
Treatment, News, Advocacy Web Team 01/07/2026 Treatment, News, Advocacy Web Team 01/07/2026

HARMONi-7: European sites now open for Phase 3 ivonescimab trial in high PD-L1 NSCLC

Read More
EU Progress on 2030 Clinical Trial Targets: What It Means for Lung Cancer
News, Advocacy, Treatment, Access Web Team 30/06/2026 News, Advocacy, Treatment, Access Web Team 30/06/2026

EU Progress on 2030 Clinical Trial Targets: What It Means for Lung Cancer

Read More
Could innovative medicines save more than they cost? What this new report means for lung cancer
Advocacy, Treatment, News, Innovation Web Team 25/06/2026 Advocacy, Treatment, News, Innovation Web Team 25/06/2026

Could innovative medicines save more than they cost? What this new report means for lung cancer

Read More
Lung cancer in women: what a new study shows about treatment side effects
Treatment, Research, News Web Team 24/06/2026 Treatment, Research, News Web Team 24/06/2026

Lung cancer in women: what a new study shows about treatment side effects

Read More
Biomarker testing is moving faster than ever. Is Europe keeping up?
Research, Treatment, Advocacy, News Web Team 20/06/2026 Research, Treatment, Advocacy, News Web Team 20/06/2026

Biomarker testing is moving faster than ever. Is Europe keeping up?

Read More
Lung cancer and heart health: understanding the two-way connection
Prevention & risk, Advocacy, News, Treatment Web Team 20/06/2026 Prevention & risk, Advocacy, News, Treatment Web Team 20/06/2026

Lung cancer and heart health: understanding the two-way connection

Read More
GLP-1 drugs and lung cancer: what the ASCO 2026 evidence shows, and what it does not
LuCE News, News, Treatment, Research Web Team 12/06/2026 LuCE News, News, Treatment, Research Web Team 12/06/2026

GLP-1 drugs and lung cancer: what the ASCO 2026 evidence shows, and what it does not

Read More
Older Posts

With Thanks to Our Supporters

Lung Cancer Europe is grateful to the partners who share our commitment to people affected by lung cancer. Their support helps us turn our mission into action across research, education and advocacy.

Accord Healthcare Amgen Bayer AstraZeneca BeOne Medicines BioNTech Blueprint Medicines Bristol Myers Squibb Boehringer Ingelheim Daiichi Sankyo Genmab Gilead Johnson & Johnson Lilly Merck Group MSD Novartis Novocure Pfizer PharmaCosmos PharmaMar Pierre Fabre Regeneron Roche Takeda Thermo Fisher

Connect with us on LinkedIn

Stay in the loop

You can subscribe to updates from Lung Cancer Europe by signing up to our monthly newsletter below. Our newsletter goes out on 1st of every month and we also send out news bulletins and updates.

By signing up, you agree to receive emails from Lung Cancer Europe. You can unsubscribe at any time. Read our Privacy Policy to learn how we handle your data.

PRIVACY POLICY

© Lung Cancer Europe 2026 | Designed by Laura Jones